Augmentation of lenvatinib efficacy by topical treatment of <i>miR-634</i> ointment in anaplastic thyroid cancer.

Augmentation of lenvatinib efficacy by topical treatment of miR-634 ointment in anaplastic thyroid cancer.

Kishikawa, Masahiro; Inoue, Jun; Hamamoto, Hidetoshi; Kobayashi, Katsunori; Asakage, Takahiro; Inazawa, Johji.

Afiliação

Kishikawa M; Department of Molecular Cytogenetics, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Inoue J; Department of Head and Neck Surgery, TMDU, Tokyo, Japan.
Hamamoto H; Department of Molecular Cytogenetics, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Kobayashi K; MEDRx Co., Ltd., Kagawa, Japan.
Asakage T; MEDRx Co., Ltd., Kagawa, Japan.
Inazawa J; Department of Head and Neck Surgery, TMDU, Tokyo, Japan.

Biochem Biophys Rep ; 26: 101009, 2021 Jul.

Article em En | MEDLINE | ID: mdl-34027135

Palavras-chave

ASCT2, alanine, serine, cysteine-preferring transporter 2; ATC, anaplastic thyroid cancer; Anaplastic thyroid cancer; Lenvatinib; TS-miR, tumor suppressive microRNA; Topical treatment; miRNA therapeutics

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article